AIGH Capital Management LLC
Long book
$488.3M
Q1 2026
Positions
40
Top-10 weight
62%
concentration
Last quarter
+73.1%
SPY +14.8%
Turnover
46%
of book per quarter
Strategy in plain words
auto-generated from filingsAIGH Capital Management LLC is a concentrated fundamental stock-picker, running a $488.3M US long book across 40 positions.
The portfolio is concentrated: the top 10 names carry 62% of the portfolio. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: SANDISK CORP, TIGO ENERGY INC, SILICON MOTION TECHNOL-ADR, ZEBRA TECHNOLOGIES CORP-CL A, NLIGHT INC.
Over the last 9 quarters its long book ran on average 11.9pp per quarter ahead of the S&P 500, beating the index in 6 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-5.0%
Q2 2024
-3.1%
Q3 2024
+11.2%
Q4 2024
-19.8%
Q1 2025
+16.6%
Q2 2025
+24.9%
Q3 2025
+24.0%
Q4 2025
+26.0%
Q1 2026
+73.1%
Sector allocation
Technology 44%
Healthcare 42%
Industrials 11%
Financials 3%
Long book by quarter
What does AIGH Capital own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| SNDK SANDISK CORP | Technology | 200.0K | $127.1M | 26.0% | -28.6% |
| TYGO TIGO ENERGY INC | Technology | 7.3M | $27.4M | 5.6% | New |
| ZBRA ZEBRA TECHNOLOGIES CORP-CL A | Industrials | 100.0K | $20.9M | 4.3% | New |
| LASR NLIGHT INC | Technology | 340.0K | $19.4M | 4.0% | -43.3% |
| VNDA VANDA PHARMACEUTICALS INC | Healthcare | 2.8M | $19.0M | 3.9% | +37.6% |
| PSNL PERSONALIS INC | Healthcare | 2.9M | $18.5M | 3.8% | Held |
| GNRC GENERAC HOLDINGS INC | Industrials | 90.0K | $17.6M | 3.6% | New |
| KYTX KYVERNA THERAPEUTICS INC | Healthcare | 2.0M | $17.3M | 3.5% | +33.3% |
| CSTL CASTLE BIOSCIENCES INC | Healthcare | 590.6K | $14.5M | 3.0% | -5.5% |
| APPS DIGITAL TURBINE INC | Financials | 4.9M | $14.1M | 2.9% | New |
| RRX REGAL REXNORD CORP | Industrials | 75.0K | $14.0M | 2.9% | New |
| ABEO ABEONA THERAPEUTICS INC | Healthcare | 3.1M | $13.9M | 2.8% | +55.0% |
| LRMR LARIMAR THERAPEUTICS INC | Healthcare | 3.0M | $13.5M | 2.8% | +50.0% |
| FENC FENNEC PHARMACEUTICALS INC | Healthcare | 2.0M | $12.2M | 2.5% | +25.3% |
| ESPR ESPERION THERAPEUTICS INC | Healthcare | 4.4M | $12.1M | 2.5% | +10.0% |
| ZVRA ZEVRA THERAPEUTICS INC | Healthcare | 1.2M | $11.2M | 2.3% | New |
| BDSX BIODESIX INC | Healthcare | 758.3K | $11.0M | 2.3% | New |
| IDN INTELLICHECK INC | Technology | 1.5M | $10.6M | 2.2% | +25.0% |
| VSTM VERASTEM INC | Healthcare | 2.0M | $10.6M | 2.2% | New |
| TARA PROTARA THERAPEUTIC INC | Healthcare | 1.6M | $8.5M | 1.7% | New |
| VUZI VUZIX CORP | Technology | 3.3M | $7.6M | 1.6% | New |
| PYPD POLYPID LTD | Healthcare | 1.6M | $7.0M | 1.4% | +18.7% |
| APYX APYX MEDICAL CORP | Healthcare | 1.1M | $4.1M | 0.8% | Held |
| COYA COYA THERAPEUTICS INC | Healthcare | 975.4K | $3.8M | 0.8% | Held |
| ELUT ELUTIA INC | Healthcare | 3.6M | $3.8M | 0.8% | +17.2% |
| RNXT RENOVORX INC | Healthcare | 3.7M | $3.7M | 0.8% | +30.8% |
| TLPH TALPHERA INC | Healthcare | 4.7M | $3.5M | 0.7% | Held |
| WATT ENERGOUS CORP | Technology | 215.0K | $3.4M | 0.7% | New |
| IPWR IDEAL POWER INC | Technology | 1.2M | $3.3M | 0.7% | +140.2% |
| NRXS NEURAXIS INC | Healthcare | 400.0K | $3.0M | 0.6% | Held |
| BKTI BK TECHNOLOGIES CORP | Technology | 32.6K | $2.4M | 0.5% | -84.6% |
| LPCN LIPOCINE INC | Healthcare | 200.0K | $1.6M | 0.3% | New |
| INVE IDENTIV INC | Technology | 409.2K | $1.5M | 0.3% | New |
| LPTH LIGHTPATH TECHNOLOGIES INC-A | Technology | 100.0K | $1.0M | 0.2% | -90.3% |
| RGNT REGENTIS BIOMATERIALS LTD/IS | Healthcare | 300.0K | $917K | 0.2% | New |
| APRE APREA THERAPEUTICS INC | Healthcare | 1.0M | $775K | 0.2% | +174.1% |
| BFRI BIOFRONTERA INC | Healthcare | 915.2K | $740K | 0.2% | Held |
| SMTK SMARTKEM INC | Technology | 895.4K | $204K | 0.0% | +32.7% |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | Apr 30, 2026 | 85 | $733.2M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 2, 2026 | 68 | $413.1M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Oct 31, 2025 | 76 | $354.9M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Jul 29, 2025 | 70 | $222.3M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 6, 2025 | 81 | $241.6M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 12, 2025 | 76 | $319.8M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 13, 2024 | 80 | $354.6M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 7, 2024 | 77 | $321.0M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 14, 2024 | 84 | $333.0M | canonical | SEC ↗ |
Similar funds
Sanders Capital, LLCGATES FOUNDATION TRUSTEAGLE CAPITAL MANAGEMENT LLCWoodbridge Co LtdAlecta Tjanstepension OmsesidigtMubadala Investment Co PJSCH&H International Investment, LLCNewlands Management Operations LLCINVESTOR ABIndependent Franchise Partners LLPPineStone Asset Management Inc.Pentwater Capital Management LP